Position in TARA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$960,730
+$305,833 QoQ
Shares Held
251,500
+100.1% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 120 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. TARA ranks #180 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in TARA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $960,730 | 251,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $654,897 | 125,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,422,081 | 266,807 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,367,205 | 314,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $452,076 | 149,200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $551,244 | 129,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $751,344 | 142,300 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $616,234 | 336,740 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $312,832 | 150,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $339,246 | 84,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $212,437 | 113,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $100,367 | 60,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $199,804 | 83,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $184,375 | 58,906 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $179,560 | 67,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $234,432 | 79,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $158,806 | 54,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $192,136 | 37,600 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $437,400 | 64,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $802,028 | 115,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $500,898 | 51,427 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $494,236 | 31,400 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $414,233 | 17,110 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $635,938 | 37,786 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $879,189 | 29,986 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||